Skip to content
Trial Eligibility
Menu

RTMS Targets Neural Circuits for Smoking Cessation

NCT04903028

This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Cigarette smoking is a significant public health concern. Transcranial magnetic stimulation (TMS) is a non-invasive form of brain stimulation that has already displayed remarkable potential for producing novel, non-pharmacological interventions for depression and cigarette smokers. In this study, investigators will use brain MRI to guide TMS therapy for smoking cessation.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Tobacco Use
  • Cigarette Smoking

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
22 to 70 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Medical University of South Carolina
Last updated on ClinicalTrials.gov
April 16, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

South Carolina · 2

  • Medical University of South Carolina · Charleston, SC
  • Medical University of South Carolina · Charleston, SC

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.